About this item:

351 Views | 302 Downloads

Author Notes:

D.T.O. (email: david.okou@emory.edu)

Design of the study: D.T.O., S.V., L.A.D., S.K.; Data generation: S.V., L.A.D., I.J., A.D., S.K., D.T.O.; Data Analysis/interpretation: S.V., L.A.D., D.J.C., M.E.Z., S.K., D.T.O.; Drafting of the manuscript: S.V., D.T.O.; Manuscript content revision: S.V., L.A.D., D.J.C., M.E.Z., S.K., D.T.O.; Funding: L.D., S.K.; Material and technical Support: L.A.D., M.E.Z., S.K.

All authors have reviewed and approved the manuscript before submission.

The authors declare no competing interests.

Subjects:

Research Funding:

This study was supported by grants R01 DK098231 (L.A.D. and S.K.) and P30 DK078392 (L.A.D.) from the National Institutes of Health.

This study was also supported in part by the Emory Integrated Genomics Core (EIGC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities.

Additional support was provided by the Georgia Clinical & Translational Science Alliance of the National Institutes of Health under Award Number UL1TR002378.

Keywords:

  • Science & Technology
  • Multidisciplinary Sciences
  • Science & Technology - Other Topics
  • CROHNS-DISEASE
  • CELL
  • ASSOCIATION
  • EXPRESSION
  • RESOURCE
  • RISK
  • LOCI
  • BETA

Neutrophil GM-CSF signaling in inflammatory bowel disease patients is influenced by non-coding genetic variants

Tools:

Journal Title:

Scientific Reports

Volume:

Volume 9, Number 1

Publisher:

, Pages 9168-9168

Type of Work:

Article | Final Publisher PDF

Abstract:

Neutrophil dysfunction and GM-CSF auto-antibodies are observed in pediatric and adult patients with Crohn’s disease (CD). We associated damaging coding variants with low GM-CSF induced STAT5 stimulation index (GMSI) in pediatric CD patients and implicated variation of neutrophil GM-CSF signaling in cell function and disease complications. Because many CD patients with low GMSI do not carry damaging coding mutations, we sought to test the hypothesis that non-coding variants contribute to this phenotype. We enrolled, performed whole genome sequencing, and measured the GMSI in 77 CD and ulcerative colitis (UC) patients (24 low and 53 normal GMSI). We identified 4 non-coding variants (rs3808851, rs10974787, rs10974788 and rs10974789) in RCL1 significantly associated with variation of GMSI level (p < 0.011). They were validated in two independent cohorts with: RNAseq data (n = 50) and blood eQTL dataset (n = 31,684). These variants are in LD and affect expression of JAK2 (p 0.005 to 0.013), RCL1 (p 8.17E-13 to 2.98E-11) and AK3 (p 2.00E-68 to 3.03E-55) genes. Additionally, they influence proteins involved in differentiation of gut epithelium, inflammation, and immune system regulation. In summary, our study outlines the contribution of non-coding variants in neutrophil GM-CSF signaling and the potential importance of RCL1 and AK3 in CD pathogenesis.

Copyright information:

© 2019, The Author(s).

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote